• 1. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 4. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 5. Aggregation-induced emission enhancement in halochalcones?
  Patricia A. A. M. Vaz,Jo?o Rocha,Artur M. S. Silva New J. Chem., 2016,40, 8198-8201

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Introduction to 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid (CAS No. 795263-45-5)

2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid, identified by the Chemical Abstracts Service Number (CAS No.) 795263-45-5, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This molecule has garnered attention due to its unique structural features and potential biological activities, making it a subject of interest in both academic research and drug development initiatives.

The molecular structure of 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid consists of a pyrrolidine ring substituted with a hydroxyl group at the 4-position and an acetic acid moiety at the 2-position. The stereochemistry at the 2R and 4R positions is particularly noteworthy, as it influences the compound's interactions with biological targets. This specific configuration has been the focus of recent studies exploring its pharmacological properties.

In recent years, there has been a growing interest in heterocyclic compounds for their diverse biological activities. Pyrrolidine derivatives, in particular, have shown promise as scaffolds for developing drugs targeting various diseases. The presence of a hydroxyl group in 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid enhances its potential for hydrogen bonding interactions, which is crucial for binding to biological receptors with high affinity.

One of the most compelling aspects of this compound is its potential role in modulating enzyme activity. Enzymes are central to numerous biological processes, and their inhibition or activation can lead to therapeutic effects. Studies have indicated that 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid may interact with specific enzymes by virtue of its structural features. This interaction could be leveraged to develop novel inhibitors or activators for therapeutic applications.

Recent research has also explored the compound's potential in the context of inflammation and immune response. Inflammatory pathways are implicated in a wide range of diseases, including autoimmune disorders and chronic inflammatory conditions. The ability of 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid to modulate these pathways has been investigated in preclinical models, showing promising results in reducing inflammation and alleviating symptoms associated with inflammatory diseases.

The stereochemical purity of 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid is another critical factor that contributes to its efficacy. The R configuration at the 2-position and the R configuration at the 4-position ensure that the compound maintains its biological activity without unwanted side effects. This level of stereochemical control is essential in pharmaceutical development, as even minor changes in stereochemistry can significantly alter a drug's properties.

Moreover, the synthesis of 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid has been optimized to ensure high yield and purity. Advanced synthetic methodologies have been employed to achieve the desired stereochemical outcome, making it feasible for large-scale production. These advancements in synthetic chemistry have enabled researchers to explore more complex derivatives of this compound, further expanding its potential applications.

The pharmacokinetic properties of 2-(2R,4R)-4-hydroxypyrrolidin-2-ylacetic acid have also been studied to understand how it behaves within the body. Factors such as absorption, distribution, metabolism, and excretion (ADME) are crucial for determining a drug's efficacy and safety. Preliminary studies suggest that this compound exhibits favorable pharmacokinetic profiles, making it a promising candidate for further development.

In conclusion, 795263-45-5 represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential biological activities make it a valuable compound for drug discovery and development. As research continues to uncover new applications for this molecule, 795263-45-5 is poised to play a crucial role in addressing various health challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)